In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice.
about
EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cellsNeural Regulation of Pancreatic Cancer: A Novel Target for InterventionPretubulysin: from hypothetical biosynthetic intermediate to potential lead in tumor therapyPan-Bcl-2 inhibitor AT-101 enhances tumor cell killing by EGFR targeted T cellsRon knockdown and Ron monoclonal antibody IMC-RON8 sensitize pancreatic cancer to histone deacetylase inhibitors (HDACi)Extracellular vesicles secreted from cancer cell lines stimulate secretion of MMP-9, IL-6, TGF-β1 and EMMPRINErk2 phosphorylation of Drp1 promotes mitochondrial fission and MAPK-driven tumor growth.Analysis of mRNA profiles after MEK1/2 inhibition in human pancreatic cancer cell lines reveals pathways involved in drug sensitivity.Clinical, molecular and genetic validation of a murine orthotopic xenograft model of pancreatic adenocarcinoma using fresh human specimensInhibition of the growth of patient-derived pancreatic cancer xenografts with the MEK inhibitor trametinib is augmented by combined treatment with the epidermal growth factor receptor/HER2 inhibitor lapatinibInhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment.A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer.Detection of pancreatic carcinomas by imaging lactose-binding protein expression in peritumoral pancreas using [18F]fluoroethyl-deoxylactose PET/CTOn the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model.Tolfenamic acid and pancreatic cancer growth, angiogenesis, and Sp protein degradation.Complementarity of ultrasound and fluorescence imaging in an orthotopic mouse model of pancreatic cancer.Lack of host SPARC enhances vascular function and tumor spread in an orthotopic murine model of pancreatic carcinoma.Subcloning and characterization of highly metastatic cells derived from human esophageal squamous cell carcinoma KYSE150 cells by in vivo selection.Secreted interleukin-1alpha induces a metastatic phenotype in pancreatic cancer by sustaining a constitutive activation of nuclear factor-kappaBGuidelines for the welfare and use of animals in cancer research.ALDH activity selectively defines an enhanced tumor-initiating cell population relative to CD133 expression in human pancreatic adenocarcinoma.The RON-receptor regulates pancreatic cancer cell migration through phosphorylation-dependent breakdown of the hemidesmosome.Losartan slows pancreatic tumor progression and extends survival of SPARC-null mice by abrogating aberrant TGFβ activation.Nicotine induces inhibitor of differentiation-1 in a Src-dependent pathway promoting metastasis and chemoresistance in pancreatic adenocarcinoma.Longitudinal Bioluminescence Imaging of Primary Versus Abdominal Metastatic Tumor Growth in Orthotopic Pancreatic Tumor Models in NSG Mice.TrkBT1 induces liver metastasis of pancreatic cancer cells by sequestering Rho GDP dissociation inhibitor and promoting RhoA activation.LY2109761, a novel transforming growth factor beta receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis.Extracellular metabolic energetics can promote cancer progressionInfluence of the implantation site on the sensitivity of patient pancreatic tumor xenografts to Apo2L/TRAIL therapy.Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model.Role of the nuclear receptor coactivator AIB1-Delta4 splice variant in the control of gene transcription.Activation of c-Met and upregulation of CD44 expression are associated with the metastatic phenotype in the colorectal cancer liver metastasis model.Side population cells of pancreatic cancer show characteristics of cancer stem cells responsible for resistance and metastasis.Epithelial to mesenchymal transition contributes to drug resistance in pancreatic cancerPancreatic stellate cell models for transcriptional studies of desmoplasia-associated genes.Antisense inhibition of microRNA-21 and microRNA-221 in tumor-initiating stem-like cells modulates tumorigenesis, metastasis, and chemotherapy resistance in pancreatic cancer.Microencapsulated tumor assay: evaluation of the nude mouse model of pancreatic cancerSuccessful inhibition of intracranial human glioblastoma multiforme xenograft growth via systemic adenoviral delivery of soluble endostatin and soluble vascular endothelial growth factor receptor-2: laboratory investigationInhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma.Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas
P2860
Q24321551-B7D71862-8DB7-4216-8457-6410D7E4EE84Q26801748-00F05F5E-D78A-49AF-94BB-85916388C3ECQ28483792-481D48BA-29FF-47CA-92C6-0061A660C84EQ28485258-52694E7C-66F9-4738-B195-4BD465108FDBQ28534954-3498E95D-FF86-42B6-B3F5-B2912F9CEF76Q28535041-C47AE249-D55F-4EF3-AC26-D70AAE2110F6Q30300846-EF5E17CC-CB91-4DBC-BF18-ABF8B206FD3EQ30409158-B25DBE0B-3C8E-44A5-8DCB-74B19EB7072CQ30416415-63A479FC-1EB6-454A-93AE-4C405AEA3C7CQ30422319-FFE26962-DA08-4BF8-A67F-1F4FAC23223DQ30424344-1580F3AD-2F5E-4D7A-8F50-99C56E15953BQ30571464-22BA8B01-3EFC-4357-A949-725EB17F5786Q30945833-A0794904-18E5-4669-963E-918470324B85Q31040893-AE02AAAC-271C-445E-8C48-BD3B9F5BAFE5Q33247384-FAA2BF80-DB55-4F85-A178-35E3D714B0C5Q33427677-3B531AA7-EAB1-4226-99B5-0FC457298351Q33592374-7A9364A9-07DD-43BD-9901-FE6FDA19EB92Q33798530-009AB76D-1193-42AA-B8A5-E3EBA328B03BQ33799457-57093C1E-943A-4C2B-9EE5-205006138692Q33903753-825B25A8-8A41-4C49-8B89-6573C7D4336DQ33939548-7BE99C65-C83E-4000-9B9F-5D43DE957BFEQ34139704-7832A54C-9E8D-411F-998D-D28C1814FC71Q34163525-05BC5301-B754-464D-BA99-72549A788E8FQ34322085-885D79E7-0ECE-4F89-84CB-D03EDC49C900Q34674684-28ECDDBD-3157-46C0-92D6-138B08E409ABQ34925405-DEBC9ADA-1FBC-4A52-A152-F60D94BA9481Q34935319-FD921C5B-23E1-4A60-A6E7-1D29FAC6B1CEQ35033532-844B9CAB-A42F-4269-BC5F-419C1B2948BEQ35063836-5A67D8D4-BD1A-4533-A6E0-955C9B601395Q35088031-7EE3D072-E54C-425E-98E2-98A65773B115Q35128269-351047C0-BD53-4BE9-9CC0-F0C648BC1184Q35167775-CBB209BF-8DC7-4BE8-9F3B-060424160D26Q35192383-FE8D8382-90DE-4115-BFBE-B19A84CF07B4Q35230326-E78A3A61-357A-40CF-A754-C6E0333B6A42Q35546368-F1F771AE-697E-41E8-8CED-A67D52BFEDEEQ35552798-2F4621F7-B9F0-4695-AA28-924A8F089308Q35681564-676E41B4-5074-44B3-BF6D-0126311EC3AAQ35695799-A57B1052-E194-4975-9FFE-AC21C0E90454Q35719620-A1058C07-5553-45F4-AA3F-C30FECAE837FQ35789079-89EC78DA-FDE3-43AE-9E9D-13BD0F0308F8
P2860
In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
In vivo selection and characte ...... pic implantation in nude mice.
@ast
In vivo selection and characte ...... pic implantation in nude mice.
@en
type
label
In vivo selection and characte ...... pic implantation in nude mice.
@ast
In vivo selection and characte ...... pic implantation in nude mice.
@en
prefLabel
In vivo selection and characte ...... pic implantation in nude mice.
@ast
In vivo selection and characte ...... pic implantation in nude mice.
@en
P2093
P2860
P356
P1433
P1476
In vivo selection and characte ...... pic implantation in nude mice.
@en
P2093
P2860
P356
10.1038/SJ.NEO.7900005
P577
1999-04-01T00:00:00Z